MedPath

None

Brand Name: None

Generic Name: Nalbuphine Hydrochloride

Active
Registration Number

DRP-7176

Dosage Form

Solution for Injection (SC/IM/IV)

Issuance Date

February 1, 2022

Expiry Date

May 30, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20mg/ mL
PackagingUSP TYPE I Flint Glass Ampoule x 1mL (net content) (Box of 10 ampoules in plastic tray)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Opioid Analgesic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Nalbuphine HydrochlorideActive
Monograph: Nalbuphine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform